Research ID
hum0191-v1Release info
Latest
Research title
Development of personalized cancer vaccine targeting individual somatic mutations combined with immunoregulation of tumor microenvironment
Research overview
- Aims
- To explore prognostic biomarkers using RNAseq data from tumor tissues of resected pancreatic cancer patients
- Methods
- Analyses of gene expression and lymphocyte enrichment in the tumor tissues by using of RNA-seq data
- Participants/materials
- Patients with pancreatic cancer who underwent curative surgery
- URL
- N/A
Datasets
| Cart | Dataset ID | Type of data | Analysis method | Access criteria | Date published |
|---|---|---|---|---|---|
| DRA008575 | NGS (RNA-seq) |
| Unrestricted-access | 2019-11-09 |
Data provider
- Principal investigator
- Kazuhiro Kakimi
- Affiliation
- Department of Immunotherapeutics, The University of Tokyo Hospital
Research projects
No research projects.
Grants
| Name | Title | Project number |
|---|---|---|
KAKENHI Grant-in-Aid for Scientific Research (B) | Novel cancer immunotherapy targeting neoantigens in combination with epigenetics and immune modulatio |
|
KAKENHI Grant-in-Aid for Scientific Research (C) | Development of cancer immunotherapy targeting mutation-derived neoantigens |
|
Related publications
| Title | DOI | Dataset ID |
|---|---|---|
NK cell and IFN signatures are positive prognostic biomarkers for resectable pancreatic cancer |